Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.
Boccadoro
M
M
Catedra di Ematologia, Turin, Italie.
Avvisati
G
G
Cantonetti
M
M
Cavo-Comotti
B M
BM
Frieri
R
R
Gallamini
A
A
Gallone
G
G
Lauta
V M
VM
Liberati
M
M
Marmont
F
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use; D011994:Recombinant Proteins; D014750:Vincristine / Q000627:therapeutic use
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone